Three things to know:
1. Mr. Ferguson has more than 20 years of financial leadership experience with executive roles at medical device and biotechnology companies.
2. His resume includes a period as CFO, chief business officer and co-president at Avinger, a cardiovascular medical device company. Most recently, he served as CFO for Bossa Nova Robotics.
3. Aziyo Biologics’ latest product launch was OsteoGro V, a viable cell bone matrix to assist with bone repair.
More articles on biologics:
Appeals court reverses IU Health win in suit over near-fatal spine surgery
Dr. Ernest Braxton offers awake spinal fusion to patients in Colorado
Smith+Nephew agrees to $240M deal to acquire Integra LifeSciences’ extremity orthopedics line
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
